EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA

Completed · Phase 2 · Has a placebo group

Conditions studied: Painful Diabetic Neuropathy

In brief

The purpose of this study is to investigate the safety and efficacy of the current hard gelatin capsule formulation of NRD135S.E1 80 mg once daily in the treatment of PDPN when administered for 13 weeks.

Key facts

Study ID
NCT05480228
Run by
James P. Rathmell, MD
People needed
127
Starts
2022-09-21
Expected to finish
2025-08-31
Last updated by the study team
2026-03-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.